Experience
/
people-profiles

Incannex Healthcare

Advising Incannex Healthcare Limited (ASX:IHL) in relation to its acquisition of 100% of the share capital in USA-based APIRx Pharmaceuticals USA, LLC for US$93.3 million in an all scrip transaction. Also advising Incannex in relation to its offer and issue of loyalty option and piggyback options to eligible shareholders to raise approximately $68.2 million.

KEY PEOPLE:
No items found.

Related insights